期刊
ACTA ANAESTHESIOLOGICA SCANDINAVICA
卷 58, 期 5, 页码 630-637出版社
WILEY
DOI: 10.1111/aas.12303
关键词
-
资金
- Swiss National Science Foundation, Berne, Switzerland [33CM30_124117, 406440-131268]
- Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland
- Swiss Foundation for Anesthesia Research, Zurich, Switzerland
- Bundesprogramm Chancengleichheit, Berne, Switzerland
- CSL Behring, Berne, Switzerland
- Vifor SA, Villars-sur-Gl ne, Switzerland
- Novo Nordisk A/S, Bagsvard, Denmark
- Swiss National Science Foundation (SNF) [33CM30-124117] Funding Source: Swiss National Science Foundation (SNF)
BackgroundNovel oral anticoagulants are now encountered in patients needing emergency surgery. Knowledge and treatment options are limited. Methods and resultWe present the case of a 76-year-old patient who suffered from an acute Stanford type A aortic dissection, needing emergency surgical aortic repair. He was anticoagulated with dabigatran due to past atrial fibrillation. Despite haemodiafiltration, surgical revision and massive transfusion of packed red blood cells, fresh frozen plasma, platelets, coagulation factors, and recombinant factor VIIa, the patient died from intractable bleeding with sustained therapeutic levels of dabigatran. ConclusionAfter reviewing the literature, we summarize the limited treatment options and show possible approaches for patients treated with dabigatran needing emergency surgery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据